Drings P
Innere Medizin-Onkologie, Thoraxklinik Heidelberg-Rohrbach der LVA-Baden.
Radiologe. 1990 Apr;30(4):149-54.
In carcinoma of the lung, the treatment design and the prognosis are dependent on the histological type and anatomical spread of the tumor and also on the general condition of the patient. Evaluation of these parameters requires an extensive clinical staging program that is nonetheless slanted to the individual subjective status of each patient. We generally distinguish a standardized basic diagnostic procedure from a specialized, more detailed individual diagnostic procedure. The pretherapeutic diagnostic assessment also includes evaluating the risk of therapy for each individual patient, especially in the case of surgical intervention. Posttherapeutic complications should not cause any great problem if the risk factors have been carefully evaluated before treatment.
在肺癌中,治疗方案的设计和预后取决于肿瘤的组织学类型、解剖学扩散情况以及患者的一般状况。对这些参数的评估需要一个广泛的临床分期程序,然而该程序仍倾向于每个患者的个体主观状况。我们通常将标准化的基本诊断程序与专门的、更详细的个体诊断程序区分开来。治疗前的诊断评估还包括评估每个患者的治疗风险,尤其是在进行手术干预的情况下。如果在治疗前仔细评估了风险因素,治疗后并发症不应造成太大问题。